SecBot SecBot

Douglas Mike Day Psychedelic Therapy to Save Lives Act of 2023

H.R. 3684 Rep. Dan Crenshaw (R-TX-2) In committee
Bill text PDF
  1. Introduced May 25
  2. Committee May 25
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, May 25, 2023Next: House vote
1252d ago May 25, 2023: Referred to the House Committee on Armed Services.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
23companies, 40 filings
Subscribe to see spend
Member trades
46trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

23 companies
Companies by sector
Industrials 6Technology & Software 4Biotech & Pharma 2Communications & Media 2Consumer & Retail 2Energy 2Mining & Materials 2Medical Devices & Healthcare 1
Search all 23 companies, their asks and price moves Subscribe

Summary

Douglas "Mike" Day Psychedelic Therapy to Save Lives Act of 2023

Full summary3 paragraphs

This bill requires the Department of Defense (DOD) to award grants to eligible entities to research the treatment of certain members of the Armed Forces through the use of specified psychedelic substances (e.g., MDMA).

Specifically, the research must focus on members of the Armed Forces who are serving on active duty and have been diagnosed with post-traumatic stress, a traumatic brain injury, or chronic traumatic encephalopathy.

Under the bill, eligible entities include federal or state government entities, academic institutions, and nonprofit entities.

Library of Congress summary, May 25, 2023

Summary versions
  • Introduced in HouseMay 25, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.